This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Standalone September 2026 quarter: revenue up 175%, profit after tax turns positive
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.2 pts less than Nifty Microcap 250 and 2.0 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The Board approved standalone September 2026 quarter results: revenue was Rs 4,754.83 lakh versus Rs 1,728.09 lakh in the restated year-ago quarter after the merger; profit after tax was Rs 149.52 lakh versus a loss of Rs 1,428.08 lakh. The quarter included Rs 21.40 lakh of exceptional merger costs, and half-year operating cash flow was negative. The CEO's three-year reappointment from February 12, 2027 was approved, subject to shareholder approval.
Revenue growth and a swing to profit may support sentiment; negative cash flow is a concern, while the CEO reappointment supports continuity.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹47.55 Cr | ₹0.00 Cr | turned positive |
| Operating profit | −₹1.51 Cr | −₹0.25 Cr | loss widened |
| Profit after tax | ₹1.50 Cr | −₹0.47 Cr | turned positive |
| EBITDA margin | 3.5% | — | — |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.